Are you interested in supporting MS Ireland in the development of our online services?
People with neurological conditions and family carers are being severely impacted by the COVID-19 lockdown, according to the findings of our recent survey.
Researchers in the University of Reading are interested in hearing what people with MS have to say about the supports they would like to made available to them to support them with mental health difficulties.
NUI Galway invite you to take part in a study focusing on the experiences of dating and romantic relationships for Irish adults living with MS. This study may provide useful information for health professionals when working with adults living with MS.
Researchers in Italy have been gathering data to understand if having MS increases the risk of a more serious infection of COVID-19 and whether taking disease modifying therapies may add an extra layer of risk.
MS data sharing during the coronavirus pandemic.
This week, MedDay Pharmaceuticals announced that the second pivotal Phase 3 trial (SPI2) of MD1003 (biotin), an investigational product for primary and secondary progressive MS has failed to meet its primary and secondary endpoints.
MS Index highlights severe lack of specialist healthcare services for people living with MS in Ireland
The Futureproofing Healthcare MS Index focuses on the treatment of MS across 30 European countries, with Ireland ranking in bottom third overall
A cognitive occupation-based programme for people with multiple sclerosis: A randomised controlled pilot trial to improve cognition and daily functioning for people with multiple sclerosis.